Clinical Trials on E.Coli Infections in Belgium

Total 1431 results

University Ghent
Pfizer; University Hospital, Ghent

Completed

Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia (UGENT_LIMOP)

Pneumonia

Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers

Respiratory Disorders

Belgium
Grand Medical Pty Ltd.
Trium Clinical Consulting

Completed

A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

Severe COVID-19 Pneumonia

Belgium
General Hospital Groeninge

Unknown

Procalcitonin to Guide Antibiotic Stop in Neurocritical Care Patients.

Sepsis

Belgium
Janssen R&D Ireland

Completed

A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy Participants

Healthy Participants

Belgium
Sumitomo Pharma Co., Ltd.

Not yet recruiting

First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP

Influenza

Belgium
University Hospital, Angers

Completed

HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection (HOME-CoV)

Coronavirus Infection

France, Monaco, Belgium
Universitair Ziekenhuis Brussel

Unknown

Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic

Anxiety Depression | Psychological Stress | Anxiety and Fear | Anxiety Postoperative

Belgium
Crucell Holland BV

Completed

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects

AIDS | AIDS Vaccines

Belgium
Universitaire Ziekenhuizen KU Leuven
Fund for Scientific Research, Flanders, Belgium

Unknown

Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity

End Stage Liver Disease | Hepatitis B | Carcinoma, Hepatocellular | Hepatitis B, Chronic

Belgium
Janssen R&D Ireland

Completed

A Study to Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male Patients

Healthy Male Participants

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis

Non-allergic Rhinitis

Belgium
AiCuris Anti-infective Cures AG
Medpace, Inc.

Recruiting

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PRIOH-1)

HSV Infection

United States, Italy, Belgium, France, United Kingdom, Germany, Switzerland, Argentina, Australia, Georgia, Greece, Mexico, Israel, Canada
Institut Pasteur

Completed

Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

HIV

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Herpes Zoster

Spain, Taiwan, Italy, Canada, Belgium, Finland, Korea, Republic of, Panama, Czechia
Universitair Ziekenhuis Brussel

Unknown

Protein-energy Enriched Milk for Infants With Bronchiolitis (PEMIB)

Bronchiolitis

Belgium
Impatients N.V. trading as myTomorrows
Inmunotek S.L.

No longer available

Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)

Urinary Tract Infections | Bladder Infection | Recurrent Urinary Tract Infection | Urinary Tract Infection Bacterial | Chronic Urinary Tract Infection

Czechia, Denmark, Serbia, France, Germany, Turkey, Belgium, Finland, Luxembourg, Netherlands, Norway, Romania, Slovakia, Slovenia, Sweden
IRCCS Burlo Garofolo

Recruiting

Defects of Keratinocytes Function in Dermatologic Patients

Hidradenitis Suppurativa

Italy, Germany, Austria, Belgium, France, Slovenia
National MS Center Melsbroek

Completed

Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment (PASCOMS)

Multiple Sclerosis

Belgium
Marie D'hooghe

Completed

The Effect of Covid-19 on the Disease Course of Multiple Sclerosis :Belgian Lessons Learned From Rocky I to Rocky IV (TofCoMS)

COVID-19

Belgium
Regeneron Pharmaceuticals

Completed

Safety and Tolerability of Regeneron Anti-SARS-CoV-2 Monoclonal Antibody/Ies in Adult Healthy Volunteers as Related to COVID-19

Healthy

Belgium
Universitair Ziekenhuis Brussel

Terminated

Body Composition, Bone Health and Hormonal Status in HIV-1-infected Individuals (BONBO)

HIV-1 | Treatment-naïve

Belgium
University Hospital, Ghent
Flanders Institute of Biotechnology

Completed

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) (SARPAC)

COVID-19

Belgium
Erasme University Hospital

Completed

Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease

Alcoholic Liver Disease | Chronic Hepatitis C Virus

Belgium
Atriva Therapeutics GmbH
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ATR-002

Influenza

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE) (VADER)

COVID

Belgium
Queen Fabiola Children's University Hospital

Unknown

Comparison of Intrapleural Urokinase and Video-Assisted Thorascopic Surgery in the Treatment of Parapneumonic Pleural Effusion in Children (UROVATS)

Empyema, Pleural

Belgium
University Hospital, Antwerp

Completed

Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 (VICAR)

Respiration, Artificial | COVID-19 Acute Respiratory Distress Syndrome

Belgium
University of Liege

Completed

Perceived Stress Among ICU Medical Staff During COVID-19 Crisis (ICUcovid)

Coronavirus | Nurse's Role | Professional Stress

Belgium
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine (NOR-107)

Healthy Volunteers | Norovirus, Prevention

Belgium
University Hospital, Ghent

Recruiting

Research on Underlying Causes of Long-term Use of Nasal Decongestants and the Structured Withdrawal of the Decongestant

Rhinitis Medicamentosa

Belgium
Pfizer

Completed

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

Hepatitis C

Belgium, Germany, United Kingdom
Thrombosis Research Institute
Sanofi

Terminated

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients (ETHIC)

COVID-19

Australia, Belgium, South Africa
Universitaire Ziekenhuizen KU Leuven

Completed

Preoperative Staging of Endometriosis With MRI (IDEAL)

Endometriosis

Belgium
Brugmann University Hospital

Completed

Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19

Covid19

Belgium, Italy, France
Erasme University Hospital
University of Liege; Universitair Ziekenhuis Brussel; University Hospital, Lille and other collaborators

Completed

The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria (BiRT)

Bacteriuria | Urinary Tract Infections | Kidney Transplantation | Asymptomatic Bacteriuria

Belgium, France
KU Leuven

Completed

Improved Use of Antibiotic Guidelines in Hospital Environment

Community-Acquired Pneumonia

Belgium
University Hospital, Ghent

Completed

Cluster-RCT Collective Nasopharyngeal COVID-19 Testing Amongst Pupils

Parents | Peer Group

Belgium
GlaxoSmithKline

Completed

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

Hepatitis B

Belgium, Canada, Sweden
Bharat Biotech International Limited

Active, not recruiting

Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers (Nasal154PH3)

COVID-19 Respiratory Infection

India
Atea Pharmaceuticals, Inc.

Completed

Study of AT-527 in Healthy and HCV-Infected Subjects

Hepatitis C | Hepatitis C, Chronic | Chronic Hepatitis C

Belgium, Moldova, Republic of
Universitaire Ziekenhuizen KU Leuven

Completed

Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients

Hemodialysis | Renal Transplantation

Belgium
Universiteit Antwerpen
Belgian Antibiotic Policy Coordination Committee (BAPCOC)

Completed

TRACE E-learning Implementation in Belgium

Respiratory Tract Infections

Belgium
Universiteit Antwerpen

Completed

Immunogenicity After COVID-19 Vaccines in Adapted Schedules (IMCOVAS)

COVID-19 | Coronavirus Disease 2019

Belgium
University of Glasgow
Universitaire Ziekenhuizen KU Leuven; Campus Bio-Medico University; Thorax Centrum... and other collaborators

Withdrawn

Outcomes of Total Arterial Coronary Artery Bypass Grafting (MOZART)

Coronary Artery Disease | Surgical Wound Infection

United Kingdom, Belgium, Italy, Netherlands
Novartis Vaccines

Completed

Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects

Human Influenza

Belgium
GlaxoSmithKline

Completed

Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine

Hepatitis B

Australia, Belgium
Centre Hospitalier Universitaire Brugmann

Unknown

Grip Test in Ventilated ICU Patients (griptest92)

Mechanically Ventilated ICU Patients

Belgium
Foundation for Innovative New Diagnostics, Switzerland
Institute of Tropical Medicine, Belgium; Nigerian Institute of Medical Research and other collaborators

Completed

Evaluation Study of RDTs Detecting Antibodies Against HCV

Hepatitis C

Belgium, Georgia, Nigeria

Clinical Trials on E.Coli Infections in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations